Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future of drug development: the economics of pharmacogenomics.

Expert review of clinical pharmacology·2014
Same author

Considering the economic principles of pharmaceutical R&D.

Expert opinion on drug discovery·2013
Same author

Measuring the patient health, societal and economic benefits of US pediatric therapeutics legislation.

Paediatric drugs·2012
Same author

The case for less, not more, US FDA regulation.

PharmacoEconomics·2011
Same author

Correctly measuring drug development risk: a public policy imperative.

Expert review of pharmacoeconomics & outcomes research·2011
Same author

Comparative effectiveness regulations and pharmaceutical innovation.

PharmacoEconomics·2010

Related Experiment Video

Updated: Jul 11, 2026

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm
11:53

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm

Published on: December 10, 2012

A primer on dynamic optimization and optimal control in pharmacoeconomics.

John A Vernon1, W Keener Hughen

  • 1Department of Finance and Center for Healthcare and Insurance Studies, Graduate School of Business, The University of Connecticut and the National Bureau of Economic Research (NBER), Storrs, CT 06269, USA. jvernon@business.uconn.edu

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|April 22, 2006
PubMed
Summary

Pharmacoeconomics can improve healthcare resource allocation by adopting dynamic optimization and control theory. This approach enhances critical thinking for optimal, long-term management of scarce health resources.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Related Experiment Videos

Last Updated: Jul 11, 2026

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm
11:53

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm

Published on: December 10, 2012

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Area of Science:

  • Health Economics
  • Mathematical Modeling
  • Decision Science

Background:

  • Pharmacoeconomic analyses guide efficient healthcare resource allocation.
  • Existing methods often lack dynamic perspectives.
  • Control theory is underutilized in economic cost analysis within health.

Purpose of the Study:

  • Introduce dynamic optimization and control theory to pharmacoeconomics.
  • Explore the application of these techniques to economic costs in healthcare.
  • Provide a primer for integrating dynamic perspectives into resource allocation.

Main Methods:

  • Review of control theory principles.
  • Application of dynamic optimization concepts.
  • Case examples in hyperlipidemia treatment cost analysis.

Main Results:

  • Control theory offers novel methods for pharmacoeconomic analysis.
  • Dynamic perspectives enhance understanding of long-term resource allocation.
  • Potential for more efficient and equitable distribution of health resources.

Conclusions:

  • Integrating dynamic optimization and control theory can advance pharmacoeconomics.
  • This approach necessitates critical evaluation of resource allocation over time.
  • Further research is warranted to overcome implementation challenges.